SEC Form 4 · accession 0001140361-16-084703
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Sydney
Officer — Exec VP, Sales & Marketing
Period of report
Nov 1, 2016
Accepted (ET)
Nov 3, 2016 · 3:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2016 | M | 2,500 | $14.00 | A | 2,600 | D | |
| Common Stock | Nov 1, 2016 | M | 5,000 | $20.40 | A | 7,600 | D | |
| Common Stock | Nov 1, 2016 | M | 5,000 | $0.80 | A | 12,600 | D | |
| Common Stock | Nov 1, 2016 | M | 12,500 | $20.40 | A | 25,100 | D | |
| Common StockF2 | Nov 1, 2016 | S | 24,621 | $32.5064 | D | 479 | D | |
| Common StockF3 | Nov 1, 2016 | S | 379 | $33.265 | D | 100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $14.00 | Nov 1, 2016 | M | 2,500 | D | — | Jul 30, 2024 | Common Stock | 2,500 | 0 | D |
| Stock Option (right to buy)F4 | $20.40 | Nov 1, 2016 | M | 5,000 | D | — | Nov 1, 2024 | Common Stock | 5,000 | 0 | D |
| Stock Option (right to buy)F5 | $0.80 | Nov 1, 2016 | M | 5,000 | D | — | Apr 29, 2021 | Common Stock | 5,000 | 0 | D |
| Stock Option (right to buy)F6 | $20.40 | Nov 1, 2016 | M | 12,500 | D | — | Nov 1, 2024 | Common Stock | 12,500 | 37,500 | D |
Explanation of responses
- F1The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 to $33.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.36, inclusive.
- F4The option is immediately exercisable.
- F5The options became exercisable in annual installments of 1,250 shares on April 29 in each of the years 2012, 2013, 2014 and 2015.
- F6The options became exercisable as to 12,500 shares on November 1, 2015, and as to 12,500 shares on November 1, 2016. The option becomes exercisable as to the remaining 25,000 shares in two annual installments of 12,500 on November 1, 2017 and 2018.